Subsidy for a pharmaceutical or biotech unit.
A formulation plant, an active ingredient unit, a diagnostics laboratory and a biotechnology startup are funded from different places, and the regulatory approval you are working towards usually decides which. We match the file to the approval rather than to the label.
Approval decides the route
Good manufacturing practice, a laboratory accreditation or a device licence each open a different head.
Plant and laboratory, separately
Machinery support and laboratory or research support are claimed under different schemes, often together.
Filed end to end
Project report, bank appraisal, the incentive application and the claim after commissioning.
Pharma & Biotech Subsidy
Tell us the project. We come back with the schemes you qualify for.
Central schemes this sector applies under
Every figure, every deadline and the notification behind it are on the scheme’s own page.
- Pharma Capital Subsidy (RPTUAS)The technology upgradation scheme written for pharmaceutical units.
- CLCS-TUS — Credit Linked Capital SubsidyThe general technology upgradation route for plant and machinery.
- MSE-CDP — Cluster DevelopmentFor common facility centres, including testing facilities.
- MSME Innovative — Incubation, Design and IPRFor incubation, design and intellectual property support.
- CGTMSE — Collateral-Free CreditThe guarantee behind the term loan the project needs.
State policies that cover it
Where the unit is registered decides most of what it can claim. These are the policies we work with; if your state is not here, ask — the list grows as the policies are read.
Not sure which of these your project qualifies for?
Send the project details and we come back with the shortlist, in the order they have to be applied in.